class actions, disabled rights, copyright, attorneys general, online speech, law schools, obesity, New York, mortgages, legal blogs, safety, CPSC, pharmaceuticals, patent trolls, ADA filing mills, international human rights, humor, hate speech, illegal drugs, immigration law, cellphones, international law, real estate, bar associations, Environmental Protection Agency, First Amendment, insurance fraud, slip and fall, smoking bans, emergency medicine, regulation and its reform, dramshop statutes, hotels, web accessibility, United Nations, Alien Tort Claims Act, lobbyists, pools, school discipline, Voting Rights Act, legal services programs
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

FORUM

« Jim Copland on election aftermath | RAND's study on MICRA »

November 08, 2004


Vioxx suits could cost Merck $18 billion

Per a Merrill Lynch report. Various Law.com reports on the debacle: frenzied recruitment, bigger than anything but asbestos and tobacco?, popularity of New Jersey's Atlantic County, and the inevitable shareholder litigation. The New York Times reports on a powwow by anti-Vioxx lawyers. (via KevinMD).

Posted by Walter Olson at 04:46 PM | TrackBack (1)



categories:
Vioxx/Drug Litigation
Vioxx/Drug Litigation









 

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.